5ml semaglutide Obesity drugs could slow the progression of kidney disease, study shows Compounded SEMAGLUTIDE 5MG - Lyophilized

Which has fewer side effects, BPC-157 or GHK-Cu

For patients managing insulin resistance and prediabetes, a therapy that simultaneously reduces VAT and improves lipid markers addresses multiple risk factors through a single hormonal mechanism

Rapid weight loss (especially with inadequate protein intake) on these drugs might accelerate muscle protein breakdown

A study of adults without type 2 diabetes showed an average 6.3% body weight loss after three months , with continued progress through six months

Right now, theres no definite answer on whether retatrutide could be used for conditions other than weight management and diabetes